Applied dna announces closing of upsized $12 million public offering

Stony brook, n.y.--(business wire)---- $apdn #lineardna--applied dna sciences, inc., (nasdaq: apdn) (the “company” or “applied dna”), a leader in polymerase chain reaction ("pcr")-based technologies, today announced the closing of its previously announced public offering of 3,000,000 shares of its common stock (or common stock equivalents in lieu thereof), together with series a warrants to purchase up to 3,000,000 shares of its common stock and series b warrants to purchase up to 3,000,000 shares of its common sto
APDN Ratings Summary
APDN Quant Ranking